Search Tufts Medicine

Search Filters
Content type
medical-person
Need care for your condition?
Displaying 241 - 260 of 265
department
Providing cutting-edge care for even the most complex diseases through every step of treatment and recovery.
Press Releases
January 25, 2021
Internationally esteemed clinician and health equity researcher, Karen Freund, MD, MPH has been named Physician-in-Chief and Chair of the Department of Medicine at Tufts Medical Center, effective February 1. She will also assume the role of Chair of the Department of Medicine at Tufts University School of Medicine, both effective February 1.
News
March 15, 2022
For most of her life, Elizabeth Craioveanu, from Hooksett, NH, couldn’t remember ever feeling well for any extended period of time.
Patient Stories
September 27, 2022
Sixty-year-old Mary D. of Winthrop recalls waking up one morning two years ago over the New Year’s holiday and immediately realizing something wasn’t right. “My face felt a little funny,” she says. “I was putting on makeup and couldn’t close my eye correctly. By the end of the day, it was much worse.”
Patient Stories
January 1, 2019
Tufts Medical Center's Weight + Wellness patient describes his journey to stop his diabetes and lose weight.
clinical trial
...

This is a prospective, multi-center clinical study to validate the effectiveness of the Boppli Blood Pressure Monitor as compared to an invasive arterial reference. This study will evaluate the accuracy and precision of the Boppli system for continuous blood pressure monitoring by comparing SBP, DBP, and MAP against the reference methodology in pediatric and neonatal populations.
News
August 10, 2021
Every day we have the privilege of helping people heal and become their best, healthiest selves. These individuals turn to us when they are most vulnerable and trust that we will care for them safely. To serve them well, we also must be our healthiest and best selves and the best way to be healthy amidst this ongoing pandemic is vaccination.
Articles
December 20, 2019
Anxiety can be normal and a disorder. Learn from Tufts Medical Center expert on what anxiety is and tips on managing it.
Patient Stories
January 30, 2020
Mac and his team at Tufts MC refused to let cardiomyopathy take his life, so they did all they could to get him to a heart transplant.
clinical trial
...

Gore has developed and manufactures the GORE® SYNECOR Intraperitoneal Biomaterial device (GORE® SYNECOR IP Device) to offer clinicians a mesh material intended for the repair of ventral/incisional hernias that may require the addition of a nonabsorbable reinforcing or bridging material. The primary study objective is to assess SYNECOR Biomaterial performance on incisional hernia patients over an extended amount of time through multiple methods. The secondary study objective is to conduct configuration-specific assessments to address areas of medical interest.
clinical trial
...

This phase II trial tests how well an imaging procedure called fludeoxyglucose F-18 (FDG) positron emission tomography/computed tomography (PET/CT) works in predicting response to standard of care chemotherapy prior to surgery in patients with HER2-positive stage IIa-IIIc breast cancer. FDG is a radioactive tracer that is given in a vein before PET/CT imaging and helps to identify areas of active cancer. PET and CT are imaging techniques that make detailed, computerized pictures of areas inside the body.
department
The Department of Ophthalmology and New England Eye Center makes healthier possible with expert diagnosis and treatment of eye diseases and visual problems. Beyond our clinical care, we’re leading the way to the future of ophthalmic care through training and education programs, eye research and ophthalmic technology development.
clinical trial
...

This study aims to learn more about the investigational drug, ASTX727, and another drug, venetoclax, when given in combination. It also aims to evaluate potential pharmocokinetics (PK) interactions for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

The primary purpose of the study is to rule out drug-drug interactions between ASTX727 and venetoclax combination therapy.
clinical trial
...

This is a single center prospective cohort study. The cohort (interventional) patients will receive the study intervention (ABCLO). The control group retrospective patients that were previously managed at the same center, regardless of the technique or the device used to close the OA.